Comparison of Dexmedetomidine and dexamethasone in supraclavicular block for upper arm surgery

Comparison Between Dexamethasone And Dexmedetomidine As A Perineural Adjuvant In Supraclavicular Brachial Plexus Block - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098364

Enrollment

Registered

2025-12-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexemethasone: Patient will receive Injection Dexamethasone 4mg diluted with Normal Saline upto 5ml with Injection 0.5 percent bupivacaine hydrochloride 15ml with inj lignocaine with ad

Eligibility

Inclusion criteria

Inclusion criteria: Weight 50-80 kilograms ASA grade I and II All patients scheduled for elective upper limb surgeries under supraclavicular brachial plexus block

Exclusion criteria

Exclusion criteria: Patient refusal for consent Age less than 18 years and more than 60 years ASA grade III and IV Patients with abnormal coagulation profile Patients with local skin site infections Patient allergic to study drugs Pregnant and lactating mothers Failure or inadaequate supraclavivular block patient will be excluded

Design outcomes

Primary

Measure	Time frame
To compare the effects of Dexmedetomidine and Dexamethasone as a perineural adjuvant to 0.5% Bupivacaine in supraclavicular brachial plexus block.Timepoint: UPTO 6 hours	—

Secondary

Measure	Time frame
To assess the onset time and duration of sensory and motor blockade of Dexmedetomidine with 0.5% Bupivacaine for Supraclavicular brachial plexus block. To assess the onset time and duration of sensory and motor blockade of Dexamethasone with 0.5% Bupivacaine for Supraclavicular brachial plexus block. To observe time required for Rescue Analgesia in both the groups. To compare the observations of the 2 groups. Timepoint: upto 6 hours	—

Measure

Time frame

To assess the onset time and duration of sensory and motor blockade of Dexmedetomidine with 0.5% Bupivacaine for Supraclavicular brachial plexus block. To assess the onset time and duration of sensory and motor blockade of Dexamethasone with 0.5% Bupivacaine for Supraclavicular brachial plexus block. To observe time required for Rescue Analgesia in both the groups. To compare the observations of the 2 groups. Timepoint: upto 6 hours

—

Countries

India

Contacts

Public ContactDr Akanksha Agarwal

Peoples College Of Medical Sciences and Research Centre Bhopal

akankshaagarwal2020@gmail.com8989147838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026